Skip to content

The SMART Study: Can a Smartphone Application Improve Adherence to Antiretroviral Therapy?

In patients with HIV infection can a smartphone application designed to enhance patients' understanding of their illness (compared to a reminder device), increase rates of adherence to antiretroviral therapy?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000265774
Acronym
The SMART Study
Enrollment
60
Registered
2013-03-06
Start date
2013-04-01
Completion date
2013-07-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of the study is to determine whether a smartphone application is a useful tool to help patients with HIV remember and manage their medications. Specifically, we intend to compare the effectiveness of two smartphone apps with different capabilities. To do this, people who are currently living with HIV, attending the Auckland City Hospital Infectious Diseases clinic and use a smartphone are being asked to participate in this study. Participants will then be randomly allocated to one of two smartphone application groups. All participants will be asked to use their respective app for three months. It is hypothesised that participants in both groups will become more adherent to their ART medication. Specifically, it is aniticipated that the smartphone application designed to enhance patients' understanding of their HIV infection will be more effective in improving/maintaining adherence to ART.

Interventions

Participants (patients with HIV infection attending the Auckland City Hospital Infectious Diseases Unit) in the intervention group will receive an augmented smartphone application to use for three months (in addition to standard care). The application contains three components designed to facilitate adherence to antiretroviral therapy (ART); (a) 24 hour timer reminding the participant when to take their medications (b) predicted blood concentrations of medications based on medication-taking

Participants (patients with HIV infection attending the Auckland City Hospital Infectious Diseases Unit) in the intervention group will receive an augmented smartphone application to use for three months (in addition to standard care). The application contains three components designed to facilitate adherence to antiretroviral therapy (ART); (a) 24 hour timer reminding the participant when to take their medications (b) predicted blood concentrations of medications based on medication-taking as entered into the application by the patient c) graphical representation of HIV & CD4 cell activity based on predicted medication concentrations and blood tests. 1. Standard care for patients with HIV infection at Auckland City Hospital is an appointment at the Infectious Diseases outpatient clinic once every six months (with either an Infectious Diseases consultant or specialist nurse) and a blood test once every three months (to determine CD4 count and HIV viral load). There is no additional care for participants taking part in the study. 2. Participants will be only asked to enter their medication use into the application. Thus, the frequency of use will depend on the complexity of their treatment regimen. Any use of the application in addition to entering medication use is completely at the participant’s discretion.

Sponsors

University of Auckland
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Every participant must be: -on antiretroviral therapy for at least 6 months -a patient at the Auckland City Hospital Infectious Diseases clinic -over 18 years of age -have a smartphone

Exclusion criteria

Participants will be excluded from the study if they: -are under 18 years of age -do not have a smartphone -are unable to give informed consent -are unable to speak, write and read English

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026